Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/24/19 → 04/22/20 |
Funding
- Ironwood Pharmaceuticals: $21,668.75
Medpace: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Different Doses of IW-1973 over 12 Weeks in Patients with Heart Failure With Preserved Ejection Fraction
- Skopicki, Hal A (PI)
- Lawson, William (CoPI)
- Bloom, Michelle (CoPI)
- Tallman, Mark (CoPI)
Project: Research